Pharmaceutical giant Eli Lilly (LLY) smashed Wall Street forecasts with a 42.6% surge in Q4 revenue to $19.29 billion, sending its stock sharply higher. The company also issued robust full-year guidance, underscoring the transformative impact of its new generation of therapies.
New data from the luxury watch marketplace reveals a decisive pivot among collectors towards refined aesthetics and classic design, signaling a cooling of speculative frenzy and the return of the connoisseur.
Facing intensifying competition for its blockbuster drugs Wegovy and Ozempic, Danish pharmaceutical leader Novo Nordisk has issued a sobering sales outlook for 2026, projecting its first annual decline since 2017 and triggering a sharp stock sell-off.
A deadly collision off the coast of Chios has left at least 15 migrants dead and sparked a major search operation, highlighting the ongoing perils of Mediterranean migration routes amid tightening EU policies.
Fugro has mobilized a significant fleet to conduct a comprehensive geotechnical survey for TotalEnergies' 2GW NordSee Energies 1 project, a key development in Germany's offshore wind expansion and Europe's push for energy security.
Shell has agreed to sell a 20% stake in Brazil's deepwater Orca Project to Kuwait Foreign Petroleum Exploration Company (KUFPEC), reinforcing a long-standing energy partnership while maintaining operatorship and a 50% holding in the key pre-salt asset.
In his latest investor letter, hedge fund veteran David Einhorn warns that soaring market valuations, driven by AI euphoria and rampant speculation, echo past bubbles. While advocating for caution, he also reveals new value-oriented bets for his Greenlight Capital.
Regulatory milestones for two AstraZeneca cancer drugs—one in the U.S. and one in Europe—signal momentum for the pharma giant's targeted oncology pipeline, offering new hope for patients with difficult-to-treat cancers.
As Denali Therapeutics prepares to present new data on its blood-brain barrier platform at a major symposium, the company faces a pivotal moment with an upcoming FDA decision. Investors are weighing promising science against financial pressures and execution risks.
Amid a broader market selloff, Standard Chartered advises investors to look beyond short-term volatility and accumulate positions in high-quality blockchain projects like Ethereum and Solana, viewing the downturn as a strategic entry point for long-term gains.
In a stark earnings call, Palantir CEO Alex Karp framed the AI race as a clash between 'haves' and 'have-nots,' citing explosive U.S. growth and warning that reluctance in Canada and Europe could trigger political upheaval.
In a strategic move to capture the booming institutional staking market, Bitwise Asset Management has acquired Swiss-based infrastructure provider Chorus One. The deal grants Bitwise direct control over yield-generating operations as it expands its European footprint and on-chain product suite.
With days still to go before kickoff, a parallel competition for attention is already in full swing as marketers unveil star-studded teasers for their multi-million-dollar Super Bowl commercials, while prediction markets take bets on the ad lineup.
As millions tune in for the big game, advertisers are betting millions more on a mix of cutting-edge tech, health trends, and celebrity power to capture viewer attention, making this year's commercial lineup a cultural barometer of its own.
Spain has unveiled a plan to ban social media access for children under 16, part of a coordinated European push to regulate online platforms and protect minors from digital harms, as similar restrictions gain momentum worldwide.
A U.S.-backed plan to rebuild Gaza faces a critical funding shortfall, with potential donors withholding commitments over concerns that stalled talks on Hamas disarmament could reignite conflict, Reuters has learned.
Packaging solutions provider FirmaPak has acquired Ontario-based Easy Plastic Containers Corp., marking its strategic expansion into Canada and strengthening its capabilities in sectors like pharmaceuticals and personal care.
The Looije Group has launched the first phase of a significant new packaging and logistics facility in Ridderkerk, marking a strategic investment to bolster its position in the European fresh produce supply chain.
Teva Pharmaceutical Industries has staged a dramatic financial recovery, posting a $1.4 billion net profit for 2025 and igniting a massive rally in its share price. Investors are now weighing whether the generic drug giant's remarkable comeback has further to run.
Bitwise CIO Matt Hougan contends the crypto bear market began in January 2025, obscured by massive institutional ETF purchases. While Bitcoin and Ethereum saw tempered declines, altcoins plummeted. Now, with the market in 'extreme fear,' experts debate the timeline for recovery and the impact of new regulatory frameworks.
